A pilot study of adjuvant bevacizumab after neoadjuvant chemotherapy for high-risk breast cancer

被引：0
|
作者：
Mayer, E. L.
Miller, K. D.
Rugo, H. S.
Peppercorn, J. M.
Carey, L. A.
Ryabin, N.
Winer, E. P.
Burstein, H. J.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Indiana Univ, Ctr Canc, Indianapolis, IN 46204 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ N Carolina, Chapel Hill, NC 27515 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
561
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A pilot study of adjuvant bevacizumab and chemotherapy after neoadjuvant chemotherapy for high-risk breast cancer
    Mayer, E. L.
    Miller, K. D.
    Rugo, H. S.
    Peppercorn, J. M.
    Carey, L. A.
    Ryabin, N.
    Josephs, K.
    Winer, E. P.
    Burstein, H. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] From adjuvant to neoadjuvant chemotherapy for high-risk breast
    Bonadonna, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 43 - 43
  • [3] Neoadjuvant and adjuvant chemotherapy for high-risk localized prostate cancer
    Nakabayashi M.
    Oh W.K.
    [J]. Current Treatment Options in Oncology, 2004, 5 (5) : 349 - 355
  • [4] Adjuvant chemotherapy for high-risk operable breast cancer
    Buzdar, Aman U.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) : 1642 - 1644
  • [5] A pilot study of the combination of entinostat with capecitabine in high-risk breast cancer after neoadjuvant therapy
    Humphrey, Clare
    Millard, Trish Ann
    Brenin, Christiana
    Dhakal, Ajay
    Falkson, Carla Isadora
    Petroni, Gina R.
    Wages, Nolan
    Dillon, Patrick Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Pilot study of modified FOLFOX6 adjuvant chemotherapy for high-risk rectal cancer treated with neoadjuvant chemoradiotherapy
    Lee, Soo Jung
    Kang, Byung Woog
    Chae, Yee Soo
    Cho, Seung Hyun
    Kim, Hye Jin
    Park, Su Yeon
    Park, Jun Seok
    Choi, Gyu Seog
    Kim, Jong Gwang
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 29 - 34
  • [7] Pilot study of modified FOLFOX6 adjuvant chemotherapy for high-risk rectal cancer treated with neoadjuvant chemoradiotherapy
    Soo Jung Lee
    Byung Woog Kang
    Yee Soo Chae
    Seung Hyun Cho
    Hye Jin Kim
    Su Yeon Park
    Jun Seok Park
    Gyu Seog Choi
    Jong Gwang Kim
    [J]. Cancer Chemotherapy and Pharmacology, 2015, 76 : 29 - 34
  • [8] Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer
    Nishimura, Junichi
    Hasegawa, Junichi
    Noura, Shingo
    Ikeda, Kimimasa
    Yasui, Masayoshi
    Komori, Takamichi
    Tsujie, Masaki
    Yasumasa, Keigo
    Shingai, Tatsushi
    Uemura, Mamoru
    Hata, Taishi
    Matsuda, Chu
    Mizushima, Tsunekazu
    Ikeda, Masataka
    Doki, Yuichiro
    Mori, Masaki
    [J]. JOURNAL OF THE ANUS RECTUM AND COLON, 2020, 4 (03): : 108 - 113
  • [9] PREDICTIVE FACTORS OF SURVIVAL AFTER NEOADJUVANT RADIOTHERAPY AND CHEMOTHERAPY IN HIGH-RISK BREAST CANCER
    Matuschek, Christiane
    Budach, Wilfried
    Tamaskovics, Balint
    Fischer, Johannes
    Boelke, Edwin
    Corradini, Stefanie
    Kammers, Kai
    Kraemling, Carolin Nestle
    Fehm, Tanja
    Wollandt, Sylvia
    Speer, Vanessa
    Haussmann, Jan
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 163 : S38 - S39
  • [10] Neoadjuvant bevacizumab and chemotherapy in breast cancer
    Wedam, Suparna B.
    Yang, Sherry X.
    [J]. TRANSLATIONAL CANCER RESEARCH, 2012, 1 (01) : 57 - 58
12345